These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27321107)

  • 1. [Primary diffuse large B-cell lymphoma of the uterine cervix - case report].
    Kojs ZJ; Niemiec M; Papuga-Fujak B; Kojs-Pasińska E; Sawicki W
    Ginekol Pol; 2016; 87(4):318-20. PubMed ID: 27321107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary diffuse large B-cell lymphoma of the uterine cervix--a case report].
    Okudaira T; Nagasaki A; Miyagi T; Nakazato T; Taira N; Kudaka W; Maehama T; Takasu N
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1423-5. PubMed ID: 18701864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.
    Cubo AM; Soto ZM; Cruz MÁ; Doyague MJ; Sancho V; Fraino A; Blanco Ó; Puig N; Alcoceba M; González M; Sayagués JM
    Medicine (Baltimore); 2017 May; 96(19):e6846. PubMed ID: 28489772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.
    Johnston PB; LaPlant B; McPhail E; Habermann TM; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Witzig TE
    Lancet Haematol; 2016 Jul; 3(7):e309-16. PubMed ID: 27374464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Uterine Cervical Lymphoma Manifesting as Menolipsis Staged and Followed Up by FDG PET/CT.
    Zhou W; Hua F; Zuo C; Guan Y
    Clin Nucl Med; 2016 Jul; 41(7):590-3. PubMed ID: 27055133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary diffuse large B-cell lymphoma of the uterus complicated with hydronephrosis].
    Isosaka M; Hayashi T; Mitsuhashi K; Tanaka M; Adachi T; Kondo Y; Suzuki T; Shinomura Y
    Rinsho Ketsueki; 2013 Apr; 54(4):392-6. PubMed ID: 23666223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful pregnancy following treatment of primary malignant lymphoma of the uterine cervix.
    Sandvei R; Lote K; Svendsen E; Thunold S
    Gynecol Oncol; 1990 Jul; 38(1):128-31. PubMed ID: 2191905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
    J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of primary non-Hodgkin's lymphoma of the uterine cervix treated by combination chemotherapy (THP-COP).
    Nasu K; Yoshimatsu J; Urata K; Miyakawa I
    J Obstet Gynaecol Res; 1998 Apr; 24(2):157-60. PubMed ID: 9631606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma.
    Tomita N; Takasaki H; Miyashita K; Fujisawa S; Ogusa E; Matsuura S; Kishimoto K; Numata A; Fujita A; Ohshima R; Kuwabara H; Hagihara M; Hashimoto C; Takemura S; Koharazawa H; Yamazaki E; Fujimaki K; Taguchi J; Sakai R; Ishigatsubo Y
    Br J Haematol; 2013 May; 161(3):383-8. PubMed ID: 23432318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.
    Nowakowski GS; LaPlant B; Macon WR; Reeder CB; Foran JM; Nelson GD; Thompson CA; Rivera CE; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Gascoyne RD; Habermann TM; Witzig TE
    J Clin Oncol; 2015 Jan; 33(3):251-7. PubMed ID: 25135992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.
    Kumar A; Lunning MA; Zhang Z; Migliacci JC; Moskowitz CH; Zelenetz AD
    Br J Haematol; 2015 Dec; 171(5):776-83. PubMed ID: 26456939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cervical lymphoma: a rare presentation to a genitourinary medicine clinic.
    Bull L; Knowles A; Ogden S; Boag F; Naresh KN; Bower M
    Int J STD AIDS; 2013 Jul; 24(7):587-9. PubMed ID: 23970778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
    Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma.
    Xia Y; Li ZM; Shi YX; Xia ZJ; Jiang WQ; Huang HQ
    Ai Zheng; 2009 Feb; 28(2):146-9. PubMed ID: 19550126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.